Pharmaceuticals, Biotechnology and Life Sciences
LUMINA is an Advanced Minimal Residual Disease Detection Platform for Lung Cancer Harnessing the Power of Multi-omics Biomarkers and AI…
WASHINGTON, Dec. 23, 2024 (GLOBE NEWSWIRE) — 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (“60 Degrees” or the “Company”), pharmaceutical…
Inclusion of neffy on Express Scripts commercial formularies was effective November 22, 2024 and expands access to patients and caregivers managing…
CAMBRIDGE, United Kingdom and MONTREAL and VANCOUVER, British Columbia and BASEL, Switzerland, Dec. 19, 2024 (GLOBE NEWSWIRE) — Epitopea, a transatlantic…
Study Demonstrates RiskScore as a More Accurate Predictor of Breast Cancer Risk, Doubling Accuracy Compared to the Tyrer-Cuzick ModelSALT LAKE…
AUSTIN, Texas, Dec. 19, 2024 (GLOBE NEWSWIRE) — Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM” or the “Company”), a…
– The Company will focus resources on advancing its lead asset, PYX-201 – PYX-201 is a novel first-in-concept antibody-drug conjugate…
Webcast Scheduled for Thursday, January 2 at 4:30 p.m. EasternCHASKA, Minn., Dec. 19, 2024 (GLOBE NEWSWIRE) — Lifecore Biomedical, Inc.…
Tokyo, Japan and Cambridge, UK, 19 December 2024 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) –…
RYONCIL (remestemcel-L) is the first MSC product approved by FDA for any indication.RYONCIL is the first FDA-approved therapy for children…